Where does Maysher rank among its competitors?

Maysher ranks 879th amongst 878 active competitors, of which 65 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Agilent, which secured $432K in Dec, 2023.

Who are the top competitors of Maysher?

Maysher's top competitors include Siemens Healthineers, Cepheid and Agilent. Among them, Agilent secured the most recent funding round in December, 2023.

Maysher - 2026 Company Profile & Competitors

Company Details

Retailer of fiber optic components and specialized laboratory research equipment. The inventory includes dust caps for optical connectors and unilateral optogenetical patch cords designed for scientific and technical applications. Products are sourced to support research requirements in optics and neuroscience laboratories.

Key Metrics

Stage

Unfunded

Ranked

879^th among 986 competitors

Similar Companies

Cepheid & 543 more

View Maysher's full profile

Maysher has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Maysher include Siemens Healthineers, Cepheid and Agilent. Here is the list of Top 10 competitors of Maysher, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Siemens Healthineers 2017, Forchheim (Germany), Public	Provider of medical imaging laboratory diagnostics and clinical digital solutions	-	Qatar Investment Authority, Skyviews Life Science ... & 3 others	75/100
2nd	Cepheid 1996, Sunnyvale (United States), Acquired	Developer of molecular diagnostic testing solutions	$19.1M	R H Capital Partners, CampVentures & 14 others	73/100
3rd	Agilent 1995, Santa Clara (United States), Public	Developer of diversified instruments for scientific and laboratory management	-	Smile Incubator, JANA Partners & 6 others	73/100
4th	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
5th	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Novalis LifeSciences & 15 others	71/100
6th	Bruker 1960, United States, Public	Manufacturer of high-performance scientific instruments for life sciences	-	Essex Investment Management, European Innovation Council ... & 5 others	70/100
7th	Sartorius 1870, Gottingen (Germany), Public	Developer of laboratory and biopharmaceutical equipment	-	Eiffel Investment Group, Juno Investment Partners ... & 2 others	70/100
8th	Unchained Labs 2015, Pleasanton (United States), Acquired	Developer of multiplex protein stability platform for biologics	$111M	Canaan, Novo Holdings & 6 others	68/100
9th	Esco Lifesciences 1978, Singapore (Singapore), Late Stage	Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools	$200M	Vivo Capital, Novo Holdings & 3 others	67/100
10th	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
879th	Maysher Unfunded	Retailer of fiber optic components and specialized laboratory research equipment	-	-	16/100